首页> 外国专利> METHOD FOR ASSESSMENT OF THE EFFECTIVENESS OF AZILSARTAN TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE WITH ANGINA PECTORIS AND HYPERTENSION

METHOD FOR ASSESSMENT OF THE EFFECTIVENESS OF AZILSARTAN TREATMENT OF PATIENTS WITH CORONARY HEART DISEASE WITH ANGINA PECTORIS AND HYPERTENSION

机译:冠心病合并高血压合并冠心病患者阿扎拉坦治疗效果的评估方法

摘要

A method for assessment of the effectiveness of Azilsartan treatment of patients with coronary heart disease with angina pectoris and hypertension involves a comparison of patients before and after treatment. Prior to treatment with Azilsartan, 5 ml of blood is collected from the median cubital vein of a patient at rest to determine the blood fluid properties by measuring the viscosity thereof in a rotary viscometer at various biases from 0,020 dyn/cm2 to 8.8 dyn/cm2. On completion of the treatment, another 5 ml of blood is collected from the patient’s median cubital vein and a similar examination is carried out; if the viscosity of the blood at a bias of 0.3 dyn/cm2 decreases by 7.5%, compared with that before the treatment, the result of hemorheological and antianginal effect is evaluated as positive.
机译:评估阿奇沙坦治疗冠心病合并心绞痛和高血压患者疗效的方法涉及比较治疗前后的患者。在用阿齐沙坦治疗之前,从静止患者的肘部正中静脉收集5 ml血液,通过在旋转粘度计中以0,020 dyn / cm2至8.8 dyn / cm2的不同偏差测量其粘度来确定血液性质。 。治疗完成后,从患者的肘部正中静脉再采集5毫升血液,并进行类似检查;如果血液的粘度以0.3 dyn / cm2的偏差下降7.5%,则与治疗前相比,血液流变学和抗心绞痛作用的结果为阳性。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号